{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:23:45Z","timestamp":1787689425520,"version":"build-2784847793"},"reference-count":38,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ARM"],"abstract":"<jats:p>Small airway dysfunction (SAD) is a pathological process that affects the bronchioles and non-cartilaginous airways below 2 mm in diameter. This short review presents a link between SAD and IPF. Pathomorphological changes of small airways in fibrotic lungs are discussed. Additionally, functional abnormalities related to SAD measured by spirometry and oscillometry are presented. The problem of early detection and treatment of SAD as a procedure potentially capable of mitigating fibrosis is mentioned.<\/jats:p>","DOI":"10.3390\/arm92050033","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T10:29:45Z","timestamp":1725618585000},"page":"348-355","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["May Small Airways Dysfunction (SAD) Play a Role in the Idiopathic Pulmonary Fibrosis (IPF) and May SAD Be a Therapeutic Target?"],"prefix":"10.3390","volume":"92","author":[{"given":"Dariusz","family":"Ziora","sequence":"first","affiliation":[{"name":"Department of Lung Diseases and Tuberculosis, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-800 Zabrze, Poland"},{"name":"Specjalistyczny Gabinet Lekarski, 42-202 Czestochowa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/rmed.2001.1216","article-title":"The role of small airways in lung disease","volume":"96","author":"Shaw","year":"2002","journal-title":"Respir. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Barkas, G.I., Daniil, Z., and Kotsiou, O.S. (2023). The Role of Small Airway Disease in Pulmonary Fibrotic Diseases. J. Pers. Med., 13.","DOI":"10.3390\/jpm13111600"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/arm91010005","article-title":"Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis","volume":"91","author":"Zhang","year":"2023","journal-title":"Adv. Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI108811","article-title":"Small Airways in Idiopathic Pulmonary Fibrosis","volume":"60","author":"Fulmer","year":"1977","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000235722","article-title":"Small airway remodeling in idiopathic interstitial pneumonias: A pathological study","volume":"79","author":"Fernezlian","year":"2010","journal-title":"Respiration"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(19)30356-X","article-title":"Small Airways Pathology in Idiopathic Pulmonary Fibrosis: A Retrospective Cohort Study","volume":"8","author":"Verleden","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.202103-0585OC","article-title":"Small Airway Reduction and Fibrosis Is an Early Pathologic Feature of Idiopathic Pulmonary Fibrosis","volume":"204","author":"Ikezoe","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/01902148.2020.1834015","article-title":"Small airway remodeling in a sheep model of bleomycin-induced pulmonary fibrosis","volume":"46","author":"Derseh","year":"2020","journal-title":"Exp. Lung Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1164\/rccm.202401-0249OC","article-title":"Microscopic Small Airway Abnormalities Identified in Early Idiopathic Pulmonary Fibrosis In Vivo Using Endobronchial Optical Coherence Tomography","volume":"210","author":"Berigei","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rea, G., Bocchino, M., Lieto, R., Ledda, R.E., D\u2019Alto, M., Sperandeo, M., Lucci, R., Pasquinelli, P., Sanduzzi Zamparelli, S., and Bocchini, G. (2024). The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13030797"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, X., Xie, B., Ban, C., Ren, Y., Ye, Q., Zhu, M., Liu, Y., Zhang, S., Geng, J., and Jiang, D. (2022). Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis. BMC Pulm. Med., 22.","DOI":"10.1186\/s12890-022-02089-6"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yin, C., Xie, H., He, X., Zhang, Y., Zhang, A., and Li, H. (2022). Small airway dysfunction in idiopathic pulmonary fibrosis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1025814"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaip.2019.06.035","article-title":"Small Airway Dysfunction by Impulse Oscillometry in Symptomatic Patients with Preserved Pulmonary Function","volume":"8","author":"Chiu","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hu, P.W., Ko, H.K., Su, K.C., Feng, J.Y., Su, W.J., Hsiao, Y.H., and Perng, D.W. (2020). Functional parameters of small airways can guide bronchodilator use in idiopathic pulmonary fibrosis. Sci. Rep., 29.","DOI":"10.1038\/s41598-020-75597-2"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00408-016-9949-1","article-title":"Clinical Significance of Forced Oscillation Technique for Evaluation of Small Airway Disease in Interstitial Lung Diseases","volume":"194","author":"Mikamo","year":"2016","journal-title":"Lung"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1183\/09031936.93.02090846","article-title":"Total respiratory resistance and reactance in patients with diffuse interstitial lung disease","volume":"2","author":"Clement","year":"1989","journal-title":"Eur. Respir. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1183\/09059180.00001814","article-title":"French National Reference Centre; Network of Competence Centres for Rare Lung Diseases. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines","volume":"23","author":"Cottin","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.rmed.2015.06.012","article-title":"The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis","volume":"109","author":"Assayag","year":"2015","journal-title":"Respir. Med."},{"key":"ref_22","first-page":"3033","article-title":"Assessment of small airway dysfunction by impulse oscillometry (IOS) in COPD and IPF patients","volume":"27","author":"Duman","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/crj.13298","article-title":"Forced oscillation measurements in patients after lobectomy\u2013A comparative analysis with IPF and COPD patients","volume":"15","author":"Ziora","year":"2021","journal-title":"Clin. Respir. J."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mori, Y., Nishikiori, H., Chiba, H., Yamada, G., Kuronuma, K., and Takahashi, H. (2020). Respiratory reactance in forced oscillation technique reflects disease stage and predicts lung physiology deterioration in idiopathic pulmonary fibrosis. Respir. Physiol. Neurobiol., 275.","DOI":"10.1016\/j.resp.2020.103386"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1164\/rccm.202108-2007ED","article-title":"Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten","volume":"204","author":"Maher","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12931-018-0732-0","article-title":"The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis","volume":"6","author":"Usmani","year":"2018","journal-title":"Respir. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/jamp.2019.1552","article-title":"Maximizing Deep Lung Deposition in Healthy and Fibrotic Subjects During Jet Nebulization","volume":"33","author":"Samuel","year":"2020","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/thorax-2022-219391","article-title":"Inhaled pirfenidone solution (AP01) for IPF: A randomised, open-label, dose-response trial","volume":"78","author":"West","year":"2023","journal-title":"Thorax"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e002008","DOI":"10.1136\/bmjresp-2023-002008","article-title":"Systemic corticosteroids in fibrotic lung disease: A systematic review and meta-analysis","volume":"30","author":"Pitre","year":"2023","journal-title":"BMJ Open Respir. Res."},{"key":"ref_30","unstructured":"(2024, July 18). Clinicaltrials.gov, Available online: https:\/\/clinicaltrials.gov\/search?cond=IPF&intr=inhalation."},{"key":"ref_31","unstructured":"(2024, July 18). Clinicaltrials.gov, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04564183?cond=IPF&intr=inhalation&page=2&rank=19."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1164\/rccm.202405-1089ED","article-title":"Bystander No More: Small Airway Involvement in IPF","volume":"210","author":"Berger","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1164\/rccm.202311-2111LE","article-title":"MUC5B IPF Risk Variant Promotes a Muco-Secretory Phenotype and Loss of Small Airway Secretory Cells","volume":"210","author":"Kurche","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.ajpath.2020.09.001","article-title":"Pathology of idiopathic pulmonary fibrosis assessed by a combination of microcomputed tomography, histology, and immunohistochemistry","volume":"190","author":"Tanabe","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Chakraborty, A., Mastalerz, M., Ansari, M., Schiller, H.B., and Staab-Weijnitz, C.A. (2022). Emerging Roles of Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis. Cells, 11.","DOI":"10.3390\/cells11061050"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1164\/rccm.201712-2551OC","article-title":"BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis","volume":"199","author":"Prasse","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1164\/rccm.201904-0792OC","article-title":"Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs","volume":"202","author":"Carraro","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Advances in Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2543-6031\/92\/5\/33\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:49:56Z","timestamp":1760111396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2543-6031\/92\/5\/33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["arm92050033"],"URL":"https:\/\/doi.org\/10.3390\/arm92050033","relation":{},"ISSN":["2543-6031"],"issn-type":[{"value":"2543-6031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]}}}